AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease (Q46455025)

22 December 2017

title

AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease (English)

1 reference

22 December 2017

0 references

0 references

11

Edward H Schuchman

1 reference

22 December 2017

author name string

Marco A Passini

1

1 reference

22 December 2017

Shannon L Macauley

2

1 reference

22 December 2017

Michael R Huff

3

1 reference

22 December 2017

Tatyana V Taksir

4

1 reference

22 December 2017

Jie Bu

5

1 reference

22 December 2017

I-Huan Wu

6

1 reference

22 December 2017

Peter A Piepenhagen

7

1 reference

22 December 2017

James C Dodge

8

1 reference

22 December 2017

Lamya S Shihabuddin

9

1 reference

22 December 2017

Catherine R O'Riordan

10

1 reference

22 December 2017

Gregory R Stewart

12

1 reference

22 December 2017

publication date

1 May 2005

1 reference

22 December 2017

published in

Molecular Therapy

1 reference

22 December 2017

volume

11

1 reference

22 December 2017

page(s)

754-762

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Critical issues in gene therapy for neurologic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Gene therapy for the central nervous system in the lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Viral vectors for gene delivery to the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Selective and rapid uptake of adeno-associated virus type 2 in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Prevalence of lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Lysosomal storage diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Cellular pathology of lysosomal storage disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Inborn errors of mucopolysaccharide metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-l-iduronidase, by cultured human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Very low levels of high density lipoprotein cholesterol in four sibs of a family with non-neuropathic Niemann-Pick disease and sea-blue histiocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Intraneural colchicine inhibition of adenoviral and adeno-associated viral vector remote spinal cord gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Targeted retrograde gene delivery for neuronal protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Adeno-associated virus vector-mediated gene transfer to somatic cells in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-defici

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

In situ hybridization studies of retinal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.011

10.1016/J.YMTHE.2005.01.011

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15851014

1 reference

22 December 2017